Surface disinfectants are antimicrobial agents designed to inactivate or eradicate microorganisms on inert surfaces. These disinfectants destroy the cell wall of microbes or interfere with their metabolism. Surface disinfectants are more effective than sanitizers; thus, they are extensively used in hospitals and health clinics, among others. They are also used in residential and commercial sectors to maintain hygiene and safety. Surface disinfectants are available in sprays, liquid, and wipes depending on the type of use.
Healthcare-associated infections are caused in all settings of care, including hospitals, ambulatory clinics, surgical centers, and long-term care facilities such as rehabilitation facilities and nursing homes. Today, a variety of invasive equipment are used to treat patients that have the potential to cause infections, which further prompts the needfor proper sterilization. Healthcare-associated infections include ventilator-associated pneumonia, catheter-associated urinary tract infections, and central line-associated bloodstream infections.
The Centers for Disease Control and Prevention (CDC) is actively working to monitor and prevent these infections to ensure the utmost patient safety and prevent infections, further driving the market growth. Rising prevalence of HAI has compelled the healthcare organizations to use surface disinfectants to avoid infections and related deaths. As per the report published by the Centers for Disease Control (CDC), in the U.S., about 1.7 million cases of infections are caused in hospitals with about 99,000 deaths every year. The CDC states that HAI, surgical site infection, pneumonia, and bloodstream infections account for about 32%, 22%, 15%, and 14% of the cases, respectively.
The pandemic has created havoc across the globe, with death tolls increasing every day at a concerning rate. The healthcare facilities are proactively working to maintain hygiene in order to treat patients efficiently. Thus, the need for constant sterilization is surging the demand for disinfectants and sanitizers across the globe. They are also witnessing huge demand among the residential sector to keep places sanitized and avoid the risk of coronavirus. However, the burgeoning demand for surface disinfectants and sanitizers has created a shortage, and the prices are soaring.
As of April 16, 2020, the total number of COVID-19 cases reached 2.1 million globally. The governments and healthcare professionals are continuously working to provide the best facilities to decelerate the death toll.Severely infected patients require ventilators, catheters, and other instruments for treatment, which increases the chances of hospital-acquired infections, further prompting the need for surface disinfectant. Canada.ca published the list of hard-surface disinfectants for emerging viral pathogens. As per Canada.ca, these surface disinfectants can also be used against SARS-CoV-2 and the coronavirus.
Drug Identification Number (DIN) |
Product name |
Company
|
Active ingredient(s) |
Product form |
00482528 |
Citrus Disinfectant
|
Chemlab, Division Of Crown Chemical Products
|
Benzalkonium Chloride,Alkyl Dimethyl Ethylbenzyl Ammonium Chloride |
Solution |
00638838 |
Air X 44 Disinfectant
|
Larose &FilsLtee |
Benzalkonium Chloride, Alkyl Dimethyl Ethylbenzyl Ammonium Chloride
|
Solution |
00801828 |
Asepticare Aerosol Disinfectant |
Airkem Professional Products, Division Of Ecolab Co. |
Benzalkonium Chloride, Alkyl Dimethyl Ethylbenzyl Ammonium Chloride, Alcohol Anhydrous |
Aerosol |
01962051 |
Buckeye Sanicare Lemon QuatLiq |
Buckeye International Inc |
Didecyl Dimethyl Ammonium Chloride, Benzalkonium Chloride |
Solution |
Source: Canada.ca
Wipes are the moistened piece of plastic or cloth that often comes folded and individually wraped for convenience. Wipes surface disinfectants are anticipated to register highest CAGR during the forecast period owing to its several benefits such as zero water consumption, fewer chances of cross-contamination compared to liquid surface disinfectants, and convenient. Wipes are extensively used for medical equipment disinfection in hospitals, especially with equipments with irregular surfaces wherein the use of sprays and liquids is very hard. Wipes are higher in cost and hence they are majorly used in the developed nations.
Spray surface disinfectant are also showing good growth at present owing to the spread of corona virus. Spray surface disinfectant can be use at a wide area in a short time whereas wipes can not be. The demand for spray surface disinfectant is on peak as of now. But they are not used in a small area application such as medical instruments and device and hence, there demand is limited as they are used mostly for the wider area application such as they are widely being used in this pendamic of Corona Virus.
North America dominates the surface disinfectant market as the region has a robust healthcare sector and leading surface disinfectant manufacturers. The U.S. is the largest producer of surface disinfectants in North America and is backed by the presence of 3M Company, Procter and Gamble, Ecolab, Johnson & Johnson, STERIS Corporation, and CarrollCLEAN. The country is also the largest producer of chemicals; for instance,as per the Chemical Industry Association, the country’s chemical industry sales exceeded USD 765 billion in 2017, and its FDI surpassed about USD 700 billion. Thus, the rapidly growing chemical industry provides an impetus to the regional market growth. In addition, various manufacturers from North America are continuously launching new products to increase there revenue. For instance, in 2017, Clorox a U.S. based company has launched Clorox Healthcare Hydrogen Peroxide Cleaner Disinfectants and Clorox Healthcare Bleach Germicidal Wipes in the U.S. market. Similarly, In 2017,3M Company launched the 3M Curos Stopper disinfecting caps. This cap protects the port of instrument from contamination.
Asia Pacific region is expected to witness the highest growth during the upcoming years owing to the presence of developing countries such as China, Japan, and India, a large population, rising number of hospitals, and growing concern regarding infectuious disease after the covid-19 outbreak. As per the WHO report of 2018, the number of beds per capita in Asia Pacific is 2.8 and 1.8 per 1000 population on average across upper-middle and lower-middle and low income Asia-Pacific countries respectively.
Copyright . All rights Reserved By Straits Research